DL-Phenylalanine Ingredients & Drug Interactions
by DC
What is this page for?
First and foremost: checking DL-Phenylalanine against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
DL-Phenylalanine is a dietary supplement by DC with 1 active ingredient. Its ingredients are commonly taken for depression and mood, skin condition vitiligo, pain conditions.Based on those ingredients, 16 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are Phenylalanine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against DL-Phenylalanine by DC
Ask about any prescription or over-the-counter medication and we check it for interactions with DL-Phenylalanine by DC — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of DL-Phenylalanine by DC
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This product contains one active ingredient: phenylalanine, an amino acid your body uses to make proteins and neurotransmitters (chemical messengers in your brain). The inactive ingredients are vegetable cellulose, silica, and vegetable magnesium stearate — all common tablet binders and fillers.
Does it work?
Moderate evidence
Phenylalanine has possibly effective evidence for vitiligo (a skin condition causing loss of pigment). For ADHD, the evidence suggests it's possibly ineffective.
The evidence isn't established in the data we hold for alcohol use disorder or multiple sclerosis.
How safe is it?
Well-documented data
Phenylalanine is generally well tolerated in typical doses. The most common side effects reported are anxiety, constipation, headache, heartburn, insomnia, nausea, and sedation.
Do not take this supplement if you have PKU (phenylketonuria), a genetic condition that prevents you from metabolizing phenylalanine safely. The safety data advises against taking supplement doses during pregnancy or while breastfeeding, so talk with your doctor or pharmacist if you're in either situation.
Meds to double-check
Major interaction found
Before starting DL-Phenylalanine, check with your doctor or pharmacist if you take levodopa (Major severity), baclofen or MAOIs (Moderate severity). These are the main medication types where phenylalanine can interfere with how your drug works or raises safety concerns.
The bottom line
Scorecard at a glanceFully disclosed formula with some supporting evidence behind its ingredients' uses. Major medication interactions have been identified, and safety information is well characterized.
This supplement may be worth considering if you're exploring options for vitiligo, but it isn't supported for ADHD. If you take levodopa, baclofen, or an MAOI antidepressant, check with your own doctor or pharmacist before adding it — the interaction with levodopa is a significant one.
The same goes if you have PKU or are pregnant or breastfeeding.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 1 of 1 active ingredient matched to our full ingredient reviews (monographs). Based on the product label dated Apr 11, 2022.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about DL-Phenylalanine, straight from the product label.
| Brand | DC |
|---|---|
| Net contents | 90 Tablet(s) |
| Market status | On market |
| Date entered into DSLD | Apr 11, 2022 |
| DSLD ID | 265716 |
| Product type | Amino Acid/protein |
| Supplement form | Tablet Or Pill |
| Dietary claims / uses | Nutrient, All Other |
| Intended target group(s) | Adult (18 - 50 Years), Women (not pregnant or lactating), Gluten Free, Dairy Free, Sugar Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for DL-Phenylalanine by DC, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Phenylalanine | 1000 mg | -- |
Other ingredients: Vegetable Cellulose, Silica, Vegetable Magnesium Stearate
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation
A racemic mixture consisting of equal parts of the D and L forms of Phenylalanine. Do not be misled by imitations or substitutions.
Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)
Conforms to USP <2091> for weight. Meets USP <2040> disintegration for maximum bioavailability.
Contains no artificial color, flavor, sweetener, preservatives, sugar, starch, milk, lactose, soy, wheat, yeast, fish and is sodium free. Gluten free
Made in USA
Precautions
Tamper Evident: Do not use this product if imprinted foil seal under cap is broken or missing.
Keep out of reach of children.
Caution: If you are pregnant or nursing do not take this product.
Phenylketonurics: Contains phenylalanine.
Storage
Keep tightly closed. Store at room temperature: 59 degrees - 86 degrees F (15 degrees to 30 degrees C).
Formula
Phenylalanine is an essential amino acid.
General Statements
Was a capsule now a tablet
Brand IP Statement(s)
Quali Pure
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Directions: As a dietary supplement, take 2 tablets 15-30 minutes before morning and evening meals.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
DL-Phenylalanine by DC label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in DL-Phenylalanine by DC
This is the 1 active ingredient this product is made of. Select it to open its full monograph.
Serving size2 Tablet(s) Dosage formTablet Or Pill Servings per container45 Amounts shown are per serving.
Phenylalanine
Interacts with16 drugs
Phenylalanine is an essential amino acid the body uses to make brain chemicals like dopamine and norepinephrine. Some people take it for mood, vitilig...
Phenylalanine monograph & interactionsOther (inactive) ingredients: Vegetable Cellulose, Silica, Vegetable Magnesium Stearate. These complete the product’s ingredient list but are not active constituents.
DL-Phenylalanine by DC Drug Interactions
HelloPharmacist Interaction Report
DL-Phenylalanine by DC can interact with several important medications.
The most serious concern is with levodopa (used for Parkinson disease): phenylalanine competes with levodopa for entry into the brain, which can reduce levodopa's effectiveness and worsen tremor, stiffness, and the unpredictable on-off pattern of symptom control — particularly at higher doses.
Read the full breakdown — every affected drug type, severity by severity
You'll also want to check if you take baclofen (a muscle relaxant). Phenylalanine can reduce how much baclofen your intestines absorb, lowering the amount that reaches your bloodstream.
Additionally, if you're on a monoamine oxidase inhibitor or MAOI (an older class of antidepressant), phenylalanine could theoretically raise your risk of a dangerous spike in blood pressure, though this is less certain than the levodopa concern.
Altogehter, these interactions span 16 individual medications. If you take any of these drug types, check your exact medications with the tool on this page before starting this supplement.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against DL-Phenylalanine?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in DL-Phenylalanine interact with 16 drugs. Click any drug to see the details.
1 of the 1 ingredient in DL-Phenylalanine interact with drugs. Each result below shows which ingredient is responsible. Phenylalanine
Benserazide, LevodopaMadopar, Prolopa
How Benserazide, Levodopa interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineLevodopa Major
Interaction Summary
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Read the full Phenylalanine + Benserazide, Levodopa interactionCarbidopa, LevodopaDhivy, Rytary, Sinemet, Sinemet CR
How Carbidopa, Levodopa interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineLevodopa Major
Interaction Summary
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Read the full Phenylalanine + Carbidopa, Levodopa interactionCarbidopa, Levodopa, EntacaponeStalevo
How Carbidopa, Levodopa, Entacapone interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineLevodopa Major
Interaction Summary
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Read the full Phenylalanine + Carbidopa, Levodopa, Entacapone interactionLevodopaInbrija, Larodopa
How Levodopa interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineLevodopa Major
Interaction Summary
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Read the full Phenylalanine + Levodopa interactionLevodopa, CarbidopaDuodopa
How Levodopa, Carbidopa interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineLevodopa Major
Interaction Summary
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Read the full Phenylalanine + Levodopa, Carbidopa interactionAmphetamineAdensys XR-ODT, Adzenys ER, Dyanavel XR, Mydayis
How Amphetamine interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Amphetamine interactionBaclofenFleqsuvy, Lioresal, Lyvispah, Ozobax
How Baclofen interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineBaclofen Moderate
Interaction Summary
Concomitant intake of phenylalanine may reduce the intestinal absorption of baclofen.
Read the full Phenylalanine + Baclofen interactionIsocarboxazidMarplan
How Isocarboxazid interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Isocarboxazid interactionLioresalLioresal Injection
How Lioresal interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineBaclofen Moderate
Interaction Summary
Concomitant intake of phenylalanine may reduce the intestinal absorption of baclofen.
Read the full Phenylalanine + Lioresal interactionMoclobemideManerix, Moclobemide
How Moclobemide interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Moclobemide interactionOzanimod HydrochlorideZeposia
How Ozanimod Hydrochloride interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Ozanimod Hydrochloride interactionPhenelzine SulfateNardil
How Phenelzine Sulfate interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Phenelzine Sulfate interactionRasagilineAzilect
How Rasagiline interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Rasagiline interactionSafinamide MesylateXadago
How Safinamide Mesylate interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Safinamide Mesylate interactionSelegilineCarbex, Eldepryl, Emsam, Zelapar
How Selegiline interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Selegiline interactionTranylcypromineParnate
How Tranylcypromine interacts with DL-Phenylalanine — through 1 ingredient. Tap an ingredient for the detail:
PhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Tranylcypromine interactionEach ingredient & the kinds of drugs it affects
For each ingredient in DL-Phenylalanine with known interactions, here are the types of medications it can affect. Open any type for the detail — or search your exact drug in the checker above.
Phenylalanine
Levodopa
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Phenylalanine competes with levodopa for carrier-mediated transport into the brain. The resulting reduction in levels of levodopa in the brain can exacerbate tremor, rigidity, and the "on-off" phenomenon in patients with Parkinson disease.
Baclofen
Concomitant intake of phenylalanine may reduce the intestinal absorption of baclofen.
Phenylalanine and baclofen share the same intestinal carrier for absorption; phenylalanine competitively inhibits the absorption of baclofen, reducing its plasma levels.
Monoamine Oxidase Inhibitors (Maois)
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
L-phenylalanine is metabolized to tyrosine. Some evidence suggests that L-phenylalanine, given with the non-selective MAOI pargyline, might prevent the elimination of tyramine, increasing the risk of hypertensive crisis. However, this was not reported in a small number of patients when using L-phenylalanine with the partially selective MAO-B inhibitor, selegiline.
Brand information
Manufacturer and brand details for DL-Phenylalanine, from the product label.
DC
See all DC products- Name
- Dee Cee Laboratories, Inc.
- Street Address
- 304 Dee Cee Ct.
- City
- White House
- State
- TN
- ZipCode
- 37188
DL-Phenylalanine by DC: Common Questions
Does DL-Phenylalanine by DC interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
What are the most common side effects?
Can I take it while pregnant or breastfeeding?
Who shouldn't take this product?
What does phenylalanine actually do?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if DL-Phenylalanine is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind DL-Phenylalanine’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sources & How We Checked
DL-Phenylalanine's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 23 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Phenylalanine 23 references
- Rouse B, Azen C, Koch R, et al. Maternal phenylketonuria collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 1997;69:89-95. DOI
- Sturtevant FM. Use of aspartame in pregnancy. Int J Fertil 1985;30:85-7.
- Silkaitis RP, Mosnaim AD. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Brain Res 1976;114:105-15.
- Lehmann WD, Theobald N, Fischer R, Heinrich HC. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine. Clin Chim Acta 1983;128 PubMed
- Mosnik DM, Spring B, Rogers K, Baruah S. Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients. Neuropsychopharmacology 1997;16:136-46. PubMed
- Siddiqui AH, Stolk LM, Bhaggoe R, et al. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 1994;88:215-8. PubMed
- Birkmayer W, Riederer P, Linauer W, Knoll J. L-deprenyl plus L-phenylalanine in the treatment of depression. J Neural Transm 1984;59:81-7. PubMed
- Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-8. PubMed
- Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-37. PubMed
- Juncos JL, Fabbrini G, Mouradian MM, et al. Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol 1987;44:1003-5. PubMed
- Eriksson T, Granerus AK, Linde A, et al. "On-off" phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38:1245-8. PubMed
- Baker GB, Bornstein RA, Rouget AC, et al. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 1991;29:15-22.. PubMed
- Wood DR, Reimherr FW, Wender PH. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Res 1985;16:21-6.. PubMed
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academy Press, 2002. Available at: http://www.n
- Cederbaum S. Phenylketonuria: an update. Curr Opin Pediatr 2002;14:702-6. PubMed
- Cejudo-Ferragud, E., Nacher, A., Polache, A., Cercos-Fortea, T., Merino, M., and Casabo, V. G. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine. Int J of Pharm (Amsterdam) 1996;132:63-69. DOI
- Fischer, E., Heller, B., Nachon, M., and Spatz, H. Therapy of depression by phenylalanine. Preliminary note. Arzneimittelforschung. 1975;25(1):132.
- Beckmann, H., Strauss, M. A., and Ludolph, E. Dl-phenylalanine in depressed patients: an open study. J.Neural Transm. 1977;41(2-3):123-134. PubMed
- Sabelli, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., Jeffriess, H., and Kravitz, H. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplem
- Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. Aromatic amino acids and modification of parkinsonism. N Engl.J Med 2-16-1967;276(7):374-379. PubMed
- Kravitz, H. M., Sabelli, H. C., and Fawcett, J. Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath.Assoc 1984;84(1 Suppl):119-123. DOI
- Mann, J., Peselow, E. D., Snyderman, S., and Gershon, S. D-phenylalanine in endogenous depression. Am.J.Psychiatry 1980;137(12):1611-1612. PubMed
- Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2010;35(5):473-6. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC